[NEOG]

Piper Sandler upgraded Neogen shares, citing progress in its turnaround. If the stock price rises and reaches the resistance level of $12.85, I will take profit; if it falls and breaks the support level of $9.05, I will cut losses. An entry may be considered following Piper Sandler’s ratings upgrade regarding turnaround progress. The current price is positioned between the resistance level of $12.85 and the support level of $9.05, and while moving averages are in a bullish alignment (short-term above long-term), a cautious approach is required as trading volume remains low at 0.45x the 20-day average. The RSI(14) stands at a neutral 53.9, and the moving averages are in a bullish alignment. Trading volume is relatively low at 0.45 times the 20-day average, and the volatility over the past 7 days was recorded at -0.1%. Surpassing the predicted return of 2.5%, the actual result recorded a return of 10.2%, receiving a final 'OVERHIT' rating. Entry was considered based on Piper Sandler's rating upgrade news and the moving averages in a bullish alignment (stacked in ascending order); however, it was judged that a cautious approach was necessary as the trading volume at the time was low at 0.45 times the 20-day average. Consequently, even amidst the low volume, turnaround momentum and the upward trend of the theme (29 news articles in the past 7 days compared to 17 previously) combined to drive a stronger-than-expected upward flow. Even when approaching conservatively due to trading volume falling below average, we confirmed that combining the sector's overall upward momentum with a rating upgrade catalyst can lead to better-than-expected performance. In future trading, we will establish a flexible response strategy by considering not only technical indicators but also the increasing trend of news momentum across the sector. There is a past precedent in the same stock (NEOG) where the 'Piper Sandler' keyword overlapped and generated a 10.2% return. Other cases, VEEE (451.7% return) and LRCX (346.8% return), are also provided for reference as top global performers, though they lack direct grounds for similarity.